47 results on '"Vos, Josephine M. I."'
Search Results
2. Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study
3. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
4. C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia
5. Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy
6. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidney
7. Clinical and clonal characteristics of monoclonal immunoglobulin M‐associated type I cryoglobulinaemia.
8. Not Everything Is as It Seems: A Case Series and Overview of Diseases Mimicking Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
9. Clinical and clonal characteristics of monoclonal immunoglobulin M‐associated type I cryoglobulinaemia
10. Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gaps
11. Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing
12. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
13. Treatment of relapsed and refractory Waldenstrom Macroglobulinemia
14. Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies
15. Dutch Physician's Perspectives on Diagnosis and Treatment of Waldenström's Macroglobulinemia Before and After the Implementation of a National Guideline
16. Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy
17. Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
18. Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment
19. High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
20. Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment.
21. Treatment of relapsed and refractory Waldenstrom Macroglobulinemia.
22. Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study
23. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression
24. Conditional relative survival in Waldenström’s macroglobulinaemia: a population‐based study in The Netherlands
25. Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989–2018
26. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
27. Conditional relative survival in Waldenström's macroglobulinaemia: a population‐based study in The Netherlands.
28. Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989–2018.
29. Evans' Syndrome in Adults: An Observational Multicentre Study
30. On Waldenström’s macroglobulinemia and IgM related disorders
31. A 43-year-old female with multifocal cerebral lesions
32. Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study
33. Waxing and waning intravascular large cell lymphoma with widespread organ infiltration
34. Waxing and waning intravascular large cell lymphoma with widespread organ infiltration.
35. The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms.
36. Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B.
37. Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study.
38. Evaluation and Management of Bing-Neel Syndrome.
39. SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study.
40. Waldenström macroglobulinemia presenting as nephrotic syndrome: Renal heavy and light chain amyloidosis.
41. Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome.
42. Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study.
43. Rare but Serious: Ibrutinib Induced Liver Failure.
44. Effective treatment of Bing-Neel Syndrome with oral fludarabine: a case series of four consecutive patients.
45. Massive haemolysis and erythrophagocytosis in Gram-negative sepsis.
46. A 43-Year-Old Female with Multifocal Cerebral Lesions. Histiocytic Sarcoma.
47. Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.